No clear answer
Fumarates / NRF2: protect nerve tissue in relapsing MS
relapsing MS · Fumarates / NRF2
Trials have tried this, but none was a controlled phase 2 or 3 trial with a readable result.
- Trials
- 2
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Dimethyl fumarate, phase 4 | Phase 4 | 0 | 2016 | Stopped | Not counted: not randomised |
| Dimethyl fumarate, phase 4 | Phase 4 | 57 | 2015 | No results found | Not counted: not randomised |
Counted: 0. Will count later: 0. Not counted: 2.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as No clear answer
Related hypotheses
Assembled by software from public sources.